Key Takeaways
- • Harvard's $57 billion endowment has approximately 79% of assets tied up in illiquid private markets, creating significant exposure risk in a contracting dealmaking environment and constraining the institution's ability to fund unfunded private equity commitments.
- • The endowment is actively selling down its private equity portfolio—Bloomberg reported Harvard is liquidating $1 billion in PE holdings—while peer institutions Yale and Princeton face similar pressures, with Yale seeking to sell up to $6 billion in alternative assets.
- • Harvard's private equity allocation was increased in 2021 when the board voted to raise risk appetite from 15% to 17.5%, a strategic decision that has coincided with underperformance relative to major stock indexes and reduced liquidity flexibility during market stress.
- • Current public equity exposure stands at only 14% of the portfolio, leaving Harvard underexposed to resilient equity markets while overcommitted to illiquid alternatives, positioning the institution unfavorably relative to endowments with greater liquid asset allocation.
- • The incoming Harvard endowment chief inherits a liquidity crisis compounded by unfunded PE commitments and slow dealmaking activity, raising questions about the institution's ability to preserve purchasing power and sustain its historical performance advantage.
Summary
Harvard University's $57 billion endowment faces a mounting liquidity crisis stemming from extreme overconcentration in private markets. With nearly 79% of assets committed to illiquid alternatives—primarily private equity—the endowment has become structurally vulnerable to the contraction in dealmaking activity now characterizing the financial sector. The institution carries billions in unfunded private equity commitments, creating a funding obligation that conflicts with the endowment's core mandate: preserving purchasing power for current and future generations of students while deploying only a modest annual spending rate.
The severity of this positioning becomes apparent when viewed against recent performance. Harvard has significantly underperformed major equity indexes, a result attributed directly to its outsized exposure to illiquid private equity and venture capital holdings. This underperformance has been compounded by the endowment's limited public equity exposure—currently just 14% of the portfolio—which has left the institution sidelined from the strong equity market performance that characterized recent years. Peer institutions Princeton and Yale have similarly suffered, with their VC and growth-stage private equity holdings dragging returns for the second consecutive year due to low domestic stock exposure.
Management's 2021 decision to increase the endowment's risk appetite from 15% to 17.5% has proven strategically problematic in hindsight. This reallocation deepened private markets exposure at precisely the wrong moment in the credit cycle, and now forces Harvard into defensive positioning. Bloomberg has reported that Harvard is actively selling $1 billion of its private equity portfolio in secondary markets, joining Yale—which is seeking buyers for up to $6 billion in alternative assets—in a coordinated retreat from positions that lack sufficient liquidity.
The incoming chief of Harvard Management Company must navigate an unfavorable backdrop: constrained dealmaking limiting exit opportunities, billions in uncalled commitments that represent future cash obligations, and a portfolio structure misaligned with both institutional liquidity needs and recent asset class performance. The endowment's historical crown as the largest and most successful university investment fund is at risk, threatened by structural illiquidity and underexposure to the public equity markets that have driven institutional returns during this cycle.
The severity of this positioning becomes apparent when viewed against recent performance. Harvard has significantly underperformed major equity indexes, a result attributed directly to its outsized exposure to illiquid private equity and venture capital holdings. This underperformance has been compounded by the endowment's limited public equity exposure—currently just 14% of the portfolio—which has left the institution sidelined from the strong equity market performance that characterized recent years. Peer institutions Princeton and Yale have similarly suffered, with their VC and growth-stage private equity holdings dragging returns for the second consecutive year due to low domestic stock exposure.
Management's 2021 decision to increase the endowment's risk appetite from 15% to 17.5% has proven strategically problematic in hindsight. This reallocation deepened private markets exposure at precisely the wrong moment in the credit cycle, and now forces Harvard into defensive positioning. Bloomberg has reported that Harvard is actively selling $1 billion of its private equity portfolio in secondary markets, joining Yale—which is seeking buyers for up to $6 billion in alternative assets—in a coordinated retreat from positions that lack sufficient liquidity.
The incoming chief of Harvard Management Company must navigate an unfavorable backdrop: constrained dealmaking limiting exit opportunities, billions in uncalled commitments that represent future cash obligations, and a portfolio structure misaligned with both institutional liquidity needs and recent asset class performance. The endowment's historical crown as the largest and most successful university investment fund is at risk, threatened by structural illiquidity and underexposure to the public equity markets that have driven institutional returns during this cycle.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.